How to optomally use CCR5 antagonists in clinical practice

Nicky Mackie, MD, Imperial College Healthcare NHS Trust, London. Participant at the Dublin course (4 September) stated: 'Really informative, enjoyable and the most useful meeting in a long time!'

 

Paris, France - 9 September
Rotterdam, The Netherlands - 15 September
Venice, Italy - 16 September
Cologne, Germany  -  10 November
 
The program
CCR5 clinical trial data
Tropism and tropism testing
Resistance among NRTI, NNRTI, PI, and Integrase inhibitors
Drug-drug interactions with CCR5 inhibitors
Presentation of clinical cases

Jonathan M. Schapiro, MD,
Sheba Medical Center        
Tel Aviv, Israel.

Charles A.B.Boucher, MD, PHD,
Erasmus Medical Center
Rotterdam, The Netherlands.

If you would like to have more information on these courses please contact Jo-Els van der Woude, Senior Event Manager Virology Education:
jo-els.vanderwoude@vironet.com